Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Neoplasms 8Breast Neoplasms 6Malnutrition 5Stomach Neoplasms 4Head and Neck Neoplasms 4Pancreatic Neoplasms 3Lung Neoplasms 3Colorectal Neoplasms 3Colonic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Prostatic Neoplasms 2Lymphoma 2Locally Advanced Head and Neck Carcinoma 2Gastrointestinal Neoplasms 2Esophageal Neoplasms 2Cachexia 2Biliary Tract Neoplasms 2Wilms Tumor 1Surgery--Complications 1Sarcoma 1Prostatic Intraepithelial Neoplasia 1Peripheral Nervous System Diseases 1Peptic Ulcer 1Osteoporosis 1Neurotoxicity Syndromes 1Neurofibromatosis 1 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1

Interventions

Megestrol Acetate 9Exercise 6Standard of Care 4Olanzapine 3Ibuprofen 3Blood Specimen Collection 3anamorelin 2Resistance Training 2Physical Therapy Modalities 2Nutrition Assessment 2Mirtazapine 2Melatonin 2Infliximab 2Dietary Supplements 2Diet Therapy 2Cyproheptadine 2testosterone enanthate 1remune 1ostarine 1olanzapine-fluoxetine combination 1nabiximols 1nabilone 1irinotecan sucrosofate 1fucoidan 1dermcidin 1clazakizumab 1bermekimab 1alkaloid GB18 1Vitamin D 1Sodium Chloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Cachexia × Dietary Supplements × Clear all
NCT02330926 2025-08-29

MENAC

Norwegian University of Science and Technology

Phase 3 Completed
221 enrolled

Cachexia, Neoplasms

NCT00851448 2011-06-02

Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Lung Cancer Patients

Fresenius Kabi

Phase NA Terminated
17 enrolled

Cachexia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡